NCT03726619 is a NA clinical trial of e-CHEC-uP in Breast Cancer, sponsored by Johns Hopkins University.

Who is sponsoring NCT03726619?

NCT03726619 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT03726619?

Interventions in NCT03726619: e-CHEC-uP, CHEC-uP.

What condition does NCT03726619 study?

NCT03726619 studies Breast Cancer, Cervical Cancer.

Is NCT03726619 still recruiting?

NCT03726619 is currently completed. Last updated 19 August 2020.

Last reviewed 2020-08-19 · How we verify

NCT03726619

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

e-CHEC-uP: Scaling up an Efficacious Cancer Screening Intervention for Women With Limited English

Completed NA Last updated 19 August 2020

What this trial tests

NA trial testing e-CHEC-uP in Breast Cancer in 40 participants. Completed in 17 August 2020.

Timeline

14 July 2019

Primary endpoint
17 August 2020

17 August 2020

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	screening
Enrollment	40
Start date	14 July 2019
Primary completion	17 August 2020
Estimated completion	17 August 2020
Sites	1 location across United States

Drugs / interventions tested

e-CHEC-uP
CHEC-uP

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Cervical Cancer — all drugs for Cervical Cancer →

Sponsor

Johns Hopkins University

Who can join

Adults 21 to 65, female only, with Breast Cancer or Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is being done to learn more about whether or not Korean American women will improve the screening practices for breast and cervical cancer if subjects receive education and follow-up from community health workers. The education materials may be given via online or in-person. Primary Hypothesis: e-CHEC-uP will be as efficacious as the original CHEC-uP in promoting mammogram and Pap test screening among Korean immigrant women (KIW) at 6 months. Objectives: (1) To develop a web-based platform of the health literacy education component of the original CHEC-uP intervention; (2) To evaluate the acceptability and usability of the web version of the health literacy education in a user testing sample of 10 KIW; and (3) To conduct a pilot study to test the preliminary efficacy of the web version of CHEC-uP (e-CHEC-uP) in 40 KIW.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Interventions for improving health literacy in migrants.
Baumeister A, Aldin A, Chakraverty D, Hübner C, et al · · 2023 · cited 22× · PMID 37963101 · DOI 10.1002/14651858.cd013303.pub2
Recruitment and Retention Strategies Among Racial and Ethnic Minorities in Web-Based Intervention Trials: Retrospective Qualitative Analysis.
Hwang DA, Lee A, Song JM, Han HR. · · 2021 · cited 22× · PMID 34255658 · DOI 10.2196/23959

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03726619 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 19 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03726619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing